Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Nana Nishizawa"'
Publikováno v:
FEBS Open Bio, Vol 13, Iss 6, Pp 1125-1133 (2023)
5‐Fluorouracil (5‐FU) is widely used for colorectal cancer (CRC) treatment; however, continuous treatment of CRC cells with 5‐FU can result in acquired resistance, and the underlying mechanism of 5‐FU resistance remains unclear. We previously
Externí odkaz:
https://doaj.org/article/bc448e2f819543bcb33321bb9f933131
Publikováno v:
FASEB BioAdvances, Vol 5, Iss 1, Pp 43-51 (2023)
Abstract 5‐Fluorouracil (5‐FU) is a cornerstone drug used to treat colorectal cancer (CRC). However, the prolonged exposure of CRC cells to 5‐FU results in acquired resistance. We have previously demonstrated that levels of the 5‐fluorodeoxyu
Externí odkaz:
https://doaj.org/article/15b6e319f65e485abb46ccb0d927b62d
Publikováno v:
ACS Omega, Vol 7, Iss 7, Pp 6046-6052 (2022)
Externí odkaz:
https://doaj.org/article/dd6129f5056e4ad892ded56f95fcdade
Publikováno v:
FASEB BioAdvances. 5:43-51
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::80db8ac2f486638e18eab9a277ad8319
https://doi.org/10.1096/fba.2022-00099
https://doi.org/10.1096/fba.2022-00099
Autor:
Nishizawa, Nana1 (AUTHOR), Kurasaka, Chinatsu1 (AUTHOR), Ogino, Yoko1 (AUTHOR), Sato, Akira1 (AUTHOR) akirasat@rs.tus.ac.jp
Publikováno v:
FASEB Bioadvances. Jan2023, Vol. 5 Issue 1, p43-51. 9p.
Publikováno v:
Cancer Science; 2024 Supplement 1, Vol. 115 Issue 1, p1-2243, 2243p
Publikováno v:
FEBS Open Bio; Jun2023, Vol. 13 Issue 6, p1125-1133, 9p